Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients
2010

Bone Density Changes After Chemotherapy in Children with Bone Sarcoma

Sample size: 46 publication 10 minutes Evidence: moderate

Author Information

Author(s): Müller Carsten, Winter Corinna C, Rosenbaum Dieter, Boos Joachim, Gosheger Georg, Hardes Jendrik, Vieth Volker

Primary Institution: University Hospital Münster

Hypothesis

Children and adolescents undergoing treatment for bone sarcomas reveal BMD decrements already after completion of neoadjuvant chemotherapy.

Conclusion

The study found no significant decrements of lumbar spine BMD in pediatric sarcoma patients after chemotherapy, but local osteopenia was observed in the affected extremity.

Supporting Evidence

  • Bone density was measured in 46 pediatric patients after chemotherapy.
  • No significant decrease in lumbar spine BMD was observed.
  • Local osteopenia was noted in the affected extremity.
  • The calcaneus showed a more pronounced reduction in BMD compared to the femoral neck.

Takeaway

Kids with bone cancer might lose some bone strength after treatment, especially in the part of the body where the tumor was, but their overall spine strength doesn't seem to change much right after treatment.

Methodology

The study used dual-energy x-ray absorptiometry (DXA) to measure bone mineral density in pediatric patients after chemotherapy.

Potential Biases

Potential biases may arise from the small sample size and the specific treatment protocols followed.

Limitations

The patient group was heterogeneous in terms of age and treatment protocols, and the lack of Tanner stage assessment limits conclusions about puberty's impact on BMD.

Participant Demographics

Participants were 46 children and adolescents aged 8-21 years, all Caucasian, with a mean age of 14.3 years.

Statistical Information

P-Value

0.016

Confidence Interval

95% CI: -0.46 to 0.18

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2474-11-287

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication